Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey
The 2012 report of the President’s Cancer Panel highlighted the overriding contribution of missed clinical opportunities to suboptimal HPV vaccination coverage. Since then, it remains unknown whether the rates of provider recommendations for the HPV vaccine in the US population have increased. We co...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-09-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.1917235 |
| _version_ | 1797674481058054144 |
|---|---|
| author | Joël Fokom Domgue Robert K. Yu Sanjay Shete |
| author_facet | Joël Fokom Domgue Robert K. Yu Sanjay Shete |
| author_sort | Joël Fokom Domgue |
| collection | DOAJ |
| description | The 2012 report of the President’s Cancer Panel highlighted the overriding contribution of missed clinical opportunities to suboptimal HPV vaccination coverage. Since then, it remains unknown whether the rates of provider recommendations for the HPV vaccine in the US population have increased. We conducted an analysis of four rounds of the Health Information National Trends Survey (HINTS), a household survey of civilian US residents aged 18 y or older. A total of 1,415 (2012), 1,476 (2014), 1,208 (2017), and 1,344 (2018) respondents to the HINTS survey who were either HPV vaccine-eligible or living with HPV vaccine-eligible individuals were included. Overall, the rates of providers’ recommendations remained stagnated from 2012 to 2018 in all categories of the study population, except for non-Hispanic Blacks (NHBs), where this prevalence increased during the study period (AAPC = 16.4%, p < .001). In vaccine-eligible individuals (18–27 y), declining trends were noted overall (AAPC = −21.6%, p < .001), among NHWs (AAPC = −30.2%, p < .001) and urban dwellers (AAPC = −21.4%, p < .001). Among vaccine-ineligible respondents (˃27 y) living with vaccine-eligible individuals, trends in the prevalence of provider recommendations for HPV vaccine were stagnating overall (AAPC = 0.5%, p = .90), and increasing only among NHBs (AAPC = 13.9%, p < .001). Despite recent progress, our findings indicate variations of trends in provider recommendations for the HPV vaccine in the US adult population according to age, sex, race/ethnicity, and residence. To accelerate HPV vaccination uptake, immediate actions to enhance provider recommendation for HPV vaccine are needed. |
| first_indexed | 2024-03-11T22:00:38Z |
| format | Article |
| id | doaj.art-66c57a6e2ae64d5b81d13dc31350770d |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T22:00:38Z |
| publishDate | 2021-09-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-66c57a6e2ae64d5b81d13dc31350770d2023-09-25T11:19:19ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2021-09-011793081308910.1080/21645515.2021.19172351917235Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends surveyJoël Fokom Domgue0Robert K. YuSanjay Shete1The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer CenterThe 2012 report of the President’s Cancer Panel highlighted the overriding contribution of missed clinical opportunities to suboptimal HPV vaccination coverage. Since then, it remains unknown whether the rates of provider recommendations for the HPV vaccine in the US population have increased. We conducted an analysis of four rounds of the Health Information National Trends Survey (HINTS), a household survey of civilian US residents aged 18 y or older. A total of 1,415 (2012), 1,476 (2014), 1,208 (2017), and 1,344 (2018) respondents to the HINTS survey who were either HPV vaccine-eligible or living with HPV vaccine-eligible individuals were included. Overall, the rates of providers’ recommendations remained stagnated from 2012 to 2018 in all categories of the study population, except for non-Hispanic Blacks (NHBs), where this prevalence increased during the study period (AAPC = 16.4%, p < .001). In vaccine-eligible individuals (18–27 y), declining trends were noted overall (AAPC = −21.6%, p < .001), among NHWs (AAPC = −30.2%, p < .001) and urban dwellers (AAPC = −21.4%, p < .001). Among vaccine-ineligible respondents (˃27 y) living with vaccine-eligible individuals, trends in the prevalence of provider recommendations for HPV vaccine were stagnating overall (AAPC = 0.5%, p = .90), and increasing only among NHBs (AAPC = 13.9%, p < .001). Despite recent progress, our findings indicate variations of trends in provider recommendations for the HPV vaccine in the US adult population according to age, sex, race/ethnicity, and residence. To accelerate HPV vaccination uptake, immediate actions to enhance provider recommendation for HPV vaccine are needed.http://dx.doi.org/10.1080/21645515.2021.1917235hpv vaccinationhealth information national trends surveyhealth-care provider recommendationdisparitiestrends |
| spellingShingle | Joël Fokom Domgue Robert K. Yu Sanjay Shete Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey Human Vaccines & Immunotherapeutics hpv vaccination health information national trends survey health-care provider recommendation disparities trends |
| title | Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey |
| title_full | Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey |
| title_fullStr | Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey |
| title_full_unstemmed | Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey |
| title_short | Trends in the rates of health-care providers’ recommendation for HPV vaccine from 2012 to 2018: a multi-round cross-sectional analysis of the health information national trends survey |
| title_sort | trends in the rates of health care providers recommendation for hpv vaccine from 2012 to 2018 a multi round cross sectional analysis of the health information national trends survey |
| topic | hpv vaccination health information national trends survey health-care provider recommendation disparities trends |
| url | http://dx.doi.org/10.1080/21645515.2021.1917235 |
| work_keys_str_mv | AT joelfokomdomgue trendsintheratesofhealthcareprovidersrecommendationforhpvvaccinefrom2012to2018amultiroundcrosssectionalanalysisofthehealthinformationnationaltrendssurvey AT robertkyu trendsintheratesofhealthcareprovidersrecommendationforhpvvaccinefrom2012to2018amultiroundcrosssectionalanalysisofthehealthinformationnationaltrendssurvey AT sanjayshete trendsintheratesofhealthcareprovidersrecommendationforhpvvaccinefrom2012to2018amultiroundcrosssectionalanalysisofthehealthinformationnationaltrendssurvey |